Poly[3,4‐dihydroxybenzhydrazide]: A Polydopamine Analogue?

Oxidative Polymerization of 3,4-Dihydroxybenzylamine─The Lower Homolog of Dopamine

Polydopamine (PDA) formed by oxidative polymerization of dopamine has attracted wide interest because of its unique properties, in particular its strong adhesion to almost all types of surfaces. 3,4-Dihydroxybenzylamine (DHBA) as the lower homolog of PDA also contains a catechol unit and an amino group and thus can be expected to exhibit a similar adhesion and reaction behavior. In fact, autoxidation of DHBA with air in 2-amino-2-hydroxymethyl-propane-1,3-diol (Tris) buffer gives rise to deeply colored oligomer/polymer products (poly(3,4-dihydroxybenzylamine) (PDHBA)) that strongly adhere to several surfaces. Here, the material is characterized by solid-state NMR spectroscopy, Fourier transform infrared (FTIR) spectroscopy, X-ray photoelectron spectroscopy (XPS), electron spin resonance (ESR) spectroscopy, mass spectrometry, and atomic force microscopy (AFM). Reaction pathways were rationalized taking into consideration the analytical results that show similarity to PDA chemistry, but also considering differences, leading to a more complex reaction behavior and thus to new structures not found in PDA.

Magnetic Nanoclusters Stabilized with Poly[3,4-Dihydroxybenzhydrazide] as Efficient Therapeutic Agents for Cancer Cells Destruction

Magnetic structures exhibiting large magnetic moments are sought after in theranostic approaches that combine magnetic hyperthermia treatment (MH) and diagnostic magnetic resonance imaging in oncology, since they offer an enhanced magnetic response to an external magnetic field. We report on the synthesized production of a core-shell magnetic structure using two types of magnetite nanoclusters (MNC) based on a magnetite core and polymer shell. This was achieved through an in situ solvothermal process, using, for the first time, 3,4-dihydroxybenzhydrazide (DHBH) and poly[3,4-dihydroxybenzhydrazide] (PDHBH) as stabilizers. Transmission electron microscopy (TEM) analysis showed the formation of spherical MNC, X-ray photoelectronic spectroscopy (XPS) and Fourier transformed infrared (FT-IR) analysis proved the existence of the polymer shell. Magnetization measurement showed saturation magnetization values of 50 emu/g for PDHBH@MNC and 60 emu/g for DHBH@MNC with very low coercive field and remanence, indicating that the MNC are in a superparamagnetic state at room temperature and are thus suitable for biomedical applications. MNCs were investigated in vitro, on human normal (dermal fibroblasts-BJ) and tumor (colon adenocarcinoma-CACO2, and melanoma-A375) cell lines, in view of toxicity, antitumor effectiveness and selectivity upon magnetic hyperthermia. MNCs exhibited good biocompatibility and were internalized by all cell lines (TEM), with minimal ultrastructural changes. By means of flowcytometry apoptosis detection, fluorimetry, spectrophotometry for mitochondrial membrane potential, oxidative stress, ELISA-caspases, and Western blot-p53 pathway, we show that MH efficiently induced apoptosis mostly via the membrane pathway and to a lower extent by the mitochondrial pathway, the latter mainly observed in melanoma. Contrarily, the apoptosis rate was above the toxicity limit in fibroblasts. Due to its coating, PDHBH@MNC showed selective antitumor efficacy and can be further used in theranostics since the PDHBH polymer provides multiple reaction sites for the attachment of therapeutic molecules.

Replacing amine by azide: Dopamine azide polymerization triggered by sodium periodate

Polydopamine (PDA) have been widely described for a range of biomedical and surface engineering applications. However the structure of PDA remains elusive due to the insoluble nature of the polymer....

1st Symposium on Polydopamine and NanoTech Poland 2018: Conference Report

The NanoTech Poland is an annual international conference with a strong scientific agenda focused on nanotechnology in energy, environment, and biomedicine. The Nanotech Poland 2018 was held at the NanoBioMedical Centre and Department of Physics at Adam Mickiewicz University in Poznań from June 6th to June 9th. The aim of NanoTech Poland 2018 was to bring together the scientific community's principal investigators, scientists, researchers, analysts, clinicians, policy makers, industry experts, and well-established and budding entrepreneurs to discuss the present and future perspectives in nanotechnology and nanoscience research and development. This year, the 1st Symposium on Polydopamine was held on June 6th. This forum was dedicated to the application of polydopamine and related catechol materials in a variety of research fields, both at the nano- and macroscale. The symposium gathered leading scientists from this important research field from top universities and institutions that have been involved in the research revolved around polydopamine. With over 200 national and international participants, NanoTech Poland 2018 and the 1st Symposium on Polydopamine provided a forum to present and discuss the latest scientific news from the field of nanotechnology with a strong interdisciplinary aspect and bioinspired materials.